Ligand validation:5GWR

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5GWR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GWR_NAD_A_301	96%	25%	0.074	0.982	1.31	1.87	5	9	0	0	100%	1
5GWR_NAD_C_301	45%	23%	0.136	0.905	1.47	1.84	4	8	0	0	80%	0.7955
5GWR_NAD_D_301	21%	19%	0.214	0.932	1.58	2.04	4	5	0	0	41%	0.4091
5GWR_NAD_B_301	18%	23%	0.213	0.834	1.34	1.98	4	7	1	0	80%	0.7955
5GWT_NAD_C_302	97%	39%	0.066	0.983	1.11	1.32	3	7	0	0	100%	1
5GWS_NAD_A_301	83%	33%	0.123	0.983	1.14	1.61	3	9	1	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.